Please use this identifier to cite or link to this item:
Appears in Collections:Computing Science and Mathematics Journal Articles
Peer Review Status: Refereed
Title: Livestock Disease Management for Trading Across Different Regulatory Regimes (Forthcoming/Available Online)
Authors: Bate, Andrew M
Jones, Glyn
Kleczkowski, Adam
Naylor, Rebecca
Timmis, Jon
White, Piran C L
Touza, Julia
Keywords: Externality
Endemic disease
Disease management
Issue Date: 12-Feb-2018
Citation: Bate AM, Jones G, Kleczkowski A, Naylor R, Timmis J, White PCL & Touza J (2018) Livestock Disease Management for Trading Across Different Regulatory Regimes (Forthcoming/Available Online), EcoHealth.
Abstract: The maintenance of livestock health depends on the combined actions of many different actors, both within and across different regulatory frameworks. Prior work recognised that private risk management choices have the ability to reduce the spread of infection to trading partners. We evaluate the efficiency of farmers' alternative biosecurity choices in terms of their own-benefits from unilateral strategies and quantify the impact they may have in filtering the disease externality of trade. We use bovine viral diarrhoea (BVD) in England and Scotland as a case study, since this provides an example of a situation where contrasting strategies for BVD management occur between selling and purchasing farms. We use an agent-based bioeconomic model to assess the payoff dependence of farmers connected by trade but using different BVD management strategies. We compare three disease management actions: test-cull, test-cull with vaccination and vaccination alone. For a two-farm trading situation, all actions carried out by the selling farm provide substantial benefits to the purchasing farm in terms of disease avoided, with the greatest benefit resulting from test-culling with vaccination on the selling farm. Likewise, unilateral disease strategies by purchasers can be effective in reducing disease risks created through trade. We conclude that regulation needs to balance the trade-off between private gains from those bearing the disease management costs and the positive spillover effects on others.
DOI Link:
Rights: © The Author(s) 2018 This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Files in This Item:
File Description SizeFormat 
s10393-018-1312-y.pdf3.44 MBAdobe PDFView/Open

This item is protected by original copyright

Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

If you believe that any material held in STORRE infringes copyright, please contact providing details and we will remove the Work from public display in STORRE and investigate your claim.